Stimulatory effect of bone morphogenetic protein‐2 on osteoclast‐like cell formation and bone‐resorbing activity

Although the action of bone morphogenetic protein (BMP) on osteoblast differentiation has been extensively investigated, its effect on osteoclast differentiation remains unknown. In the present study, in vitro effects of BMP‐2 on osteoclast‐like cell formation and bone resorption were examined. BMP‐2 (1–100 ng/ml) significantly stimulated bone resorption by preexistent osteoclast‐like cells in mouse bone cell cultures containing stromal cells, whereas it did not affect the bone‐resorbing activity of isolated rabbit osteoclast‐like cells. When BMP‐2 was added to unfractionated bone cells after degeneration of preexistent osteoclast‐like cells, BMP‐2 dose‐dependently stimulated osteoclast‐like cell formation at a minimal effective concentration of 10 pg/ml. BMP‐2 also enhanced the osteoclast‐like cell formation induced by 1,25‐dihydroxyvitamin D3 (1,25(OH)2D3). Moreover, osteoclast‐like cells newly formed by BMP‐2 from unfractionated bone cells possessed the ability to form pits on dentine slices. Because these results indicated that BMP‐2 directly or indirectly stimulated osteoclast differentiation and activity, we next examined the direct effect of BMP‐2 on osteoclast precursors in the absence of stromal cells using hemopoietic blast cells derived from spleen cells. The mRNA for BMP‐2/4 receptor was detected in hemopoietic blast cells supported by granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) as well as osteoblastic MC3T3‐E1 cells and MC3T3‐G2/PA6 stromal cells by RNase protection assay. BMP‐2 dose‐dependently stimulated osteoclast‐like cell formation from hemopoietic blast cells supported by GM‐CSF at a minimal effective concentration of 10 pg/ml. BMP‐2 also enhanced 1,25(OH)2D3‐induced osteoclast‐like cell formation from hemopoietic blast cells. The present data are the first to indicate that BMP‐2 stimulates bone resorption through both direct stimulation of osteoclast formation and activation of mature osteoclasts, possibly via stromal cells, in vitro.

[1]  A. Mason,et al.  Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. , 1991, Molecular endocrinology.

[2]  H. Koyama,et al.  A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hemopoietic stem cells in vitro , 1982, Journal of cellular physiology.

[3]  R. Ziegler,et al.  Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. , 1990, Endocrinology.

[4]  J. Hock,et al.  Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. , 1987, The Journal of clinical investigation.

[5]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[6]  E. Canalis,et al.  Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. , 1988, Endocrinology.

[7]  H. Nakauchi,et al.  Generation of osteoclasts from isolated hematopoietic progenitor cells. , 1989, Blood.

[8]  A. Reddi,et al.  Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.

[11]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Rodan,et al.  Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. , 1989, Endocrinology.

[13]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[14]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. , 1992, Endocrinology.

[15]  V. Rosen,et al.  The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. , 1990, Biochemical and biophysical research communications.

[16]  S. Colucci,et al.  Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption , 1990, The Journal of cell biology.

[17]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[18]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[19]  G. Roodman,et al.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[21]  N. Ueno,et al.  A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Takada,et al.  A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. , 1992, Bone and mineral.

[23]  M. Urist.  Bone: Formation by Autoinduction , 1965, Science.

[24]  K. Chihara,et al.  Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast‐like cells , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  A. Reddi.  Cell biology and biochemistry of endochondral bone development. , 1981, Collagen and related research.

[26]  E. Drier,et al.  OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.

[27]  M. Kumegawa,et al.  Insulin-like growth factor-I supports formation and activation of osteoclasts. , 1992, Endocrinology.

[28]  K. Chihara,et al.  Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity. , 1994, Endocrinology.

[29]  E. Ogata,et al.  Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. , 1989, Biochemical and biophysical research communications.

[30]  C. Heidelberger,et al.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. , 1973, Cancer research.

[31]  E. Froesch,et al.  Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.

[32]  K. Sumitani,et al.  Mouse osteoblastic cells (MC3T3-E1) at different stages of differentiation have opposite effects on osteoclastic cell formation. , 1991, Endocrinology.

[33]  K. Chihara,et al.  Second messenger signaling of PTH- and PTHRP-stimulated osteoclast-like cell formation from hemopoietic blast cells. , 1993, The American journal of physiology.

[34]  K. Chihara,et al.  Calcitonin inhibits osteopontin mRNA expression in isolated rabbit osteoclasts. , 1994, Endocrinology.

[35]  E. Canalis,et al.  Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. , 1989, Endocrinology.

[36]  E. Ogata,et al.  Prostaglandin F2 alpha stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. , 1991, The Journal of biological chemistry.

[37]  P. Nijweide,et al.  Identification of osteopontin in isolated rabbit osteoclasts. , 1992, Biochemical and biophysical research communications.

[38]  K. Chihara,et al.  Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation. , 1994, The American journal of physiology.

[39]  J. Wozney,et al.  Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  H. Koyama,et al.  Hormonal responsiveness of a preadipose cell line derived from newborn mouse calvaria , 1982, Journal of cellular physiology.

[41]  E. Wang,et al.  Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. , 1991, Biochemical and biophysical research communications.